Clinical Tumor Stage is the Most Important Predictor of Pathological Complete Response Rate After Neoadjuvant Chemotherapy in Breast Cancer Patients

According to researchers from Maastricht University Medical Centre, Maastricht, The Netherland, the most important predictor of pathological complete response rate (pCR) in patients with breast cancer is clinical tumor stage. Indeed, patients with lower clinical tumor stages had significantly higher pCR rates than patients with higher clinical tumor stages.

 Breast Cancer Res Treat

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.